| News
Innolith makes breakthrough in vehicle batteries
04.04.2019
Energy company Innolith has developed a new type of battery that gives electric vehicles a range of 1,000km. The innovation has now been registered for a patent and will be launched on the market via an initial pilot production.

Innolith Battery
Basel energy company Innolith has developed a battery innovation at its German laboratory in Bruchsal. According to a press release, this rechargeable battery is capable of powering an electric vehicle for over 1,000km on a single charge. The battery avoids exotic and expensive materials and therefore radically reduces overall cost.
In addition to its range and cost advantages, the new battery is also safer. It is the first non-flammable lithium-based battery for use in electric vehicles. Rather than conventional flammable organic electrolytes, the Innolith battery uses a non-flammable inorganic electrolyte.
A patent application has been filed for this battery technology and Innolith is maintaining commercial confidentiality on the cell chemistry mechanism. The chemistry used in this battery has reportedly been proven to operate for more than 55,000 full depth discharge cycles, which is between 10 and 100 times the maximum number of cycles of existing lithium ion batteries in use today.
Innolith will be bringing its Energy Battery to market via an initial pilot production in Germany soon. The aim is to later conclude licensing partnerships with battery manufacturers. BaselArea.swiss supported Innolith in 2018 with the opening of the global headquarters in Basel.
Share this article
Sign up to receive our newsletter in your inbox.
You might also be interested in
Clinerion is now part of Citeline
Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with...
Read MoreKUORI developing biodegradable plastics
The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...
Read MoreCell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...
Read MoreBLKB expanding support for startups
BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...
Read MoreCombatting the rise of antimicrobial resistance
Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...
Read MoreAMR Action Fund invests in new antibiotics developed by BioVersys
The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...
Read MoreInvestors give Resistell 8.5 million Swiss francs
Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...
Read MoreBSI integrating AI from Parashift in banking software
Parashift, the specialist in the area of smart document processing on the basis of Artificial Intelligence (AI), has entered into...
Read MoreUptownBasel joins IBM Quantum Network
UptownBasel is partnering with IBM. The emerging competence center for Industry 4.0 will provide its partners with the IBM Quantum...
Read MoreSouth Korean pharma firms show interest in the Basel Area
Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...
Read More